Skip to main navigation Skip to search Skip to main content

Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: Physician survey and good clinical practice recommendations from an international expert panel

  • Cardio-Metabolic Academy Europe East
  • Medical University of Łódź
  • Institute of Polish Mother's Health Center
  • University of Zielona Gora
  • Victor Babes University of Medicine and Pharmacy
  • Institute for Clinical and Experimental Medicine
  • University of Ljubljana
  • Sofia University St. Kliment Ohridski
  • Medical University Sofia
  • Semmelweis University
  • University of Belgrade
  • Clinical Center of Serbia
  • Charles University
  • University College London
  • Novo Nordisk Foundation
  • Hospital de Curry Cabral
  • NOVA University Lisbon
  • Lisbon Health Technology School
  • Democritus University of Thrace
  • APDP Diabetes Portugal
  • University of Palermo
  • University of South Carolina
  • Carol Davila University of Medicine and Pharmacy

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Aims: Evidence from cardiovascular outcomes trials (CVOTs) of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors was reflected in the most recent guidelines from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). The aim of the present study was to assess the adoption of the ADA/EASD guidelines in a convenience sample of physicians from Eastern and Southern Europe, the barriers to the implementation of these guidelines and the measures needed to facilitate their implementation. Methods: Attendees at two international diabetes conferences could volunteer to respond to a fully anonymous survey. Responses were analysed descriptively and a panel of experts from around the region was consulted to interpret the survey results. Results: Responses (n = 96) from 10 countries were analysed. Most participants (63.4%) considered the ADA/EASD guidelines fundamental to their practice. All respondents saw the value of the CVOT-based ADA/EASD recommendations and 77–80% generally implemented them. Measures suggested to improve adherence to the ADA/EASD guidelines included aligning reimbursement policy with the guidelines (54.4%), publishing guidelines in a simple and concise form (42.4%) and translating guidelines into local languages (33.3%). Conclusions: Aligning reimbursement with recent evidence and providing short summaries of the ADA/EASD guidelines in local languages could facilitate physician adherence.

Original languageEnglish
Article number108535
JournalDiabetes Research and Clinical Practice
Volume172
DOIs
StatePublished - Feb 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adherence
  • Clinical guidelines
  • GLP-1RAs
  • SGLT2is
  • Type 2 diabetes

Fingerprint

Dive into the research topics of 'Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: Physician survey and good clinical practice recommendations from an international expert panel'. Together they form a unique fingerprint.

Cite this